Goldsite Diagnostics Inc., is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Goldsite offers clinical instruments such as advanced medical laboratory analyzers that provide accurate and timely results to aid clinical diagnosis.
Goldsite provide full portfolio of biomarker in vitro diagnostic assays performed at clinical laboratory for COVID-19, infectious diseases, diabetes and more. Our current products include more than 50 assays, from inflammation, diabetes, rheumatoid diseases, immune disorders, hormones to cardiac markers.
Goldsite provide consumables such as high-quality disposable medical supplies widely used at the hospitals and laboratories.
Community Hospitals & Critical Access Hospitals (CAHs)Limited Lab Resources: These facilities often lack large, high-throughput automated analyzers due to space/budget constraints. A small nephelometer provides essential protein testing without a major capital investment.Moderate Test Volume: They h
Read More
November 21, 2025 (Düsseldorf, Germany) – The world’s most influential medical trade fair, MEDICA 2025, successfully concluded yesterday. Over the course of the four-day event, the Goldsite’s booth (Hall 1 / Booth 1B56) became a hub of activity, attracting professional visitors from over 60 countrie
Read More
In the fast-evolving world of diabetes diagnostics, finding the best HbA1c analyzer isn't just about speed—it's about precision, versatility, and real-world impact. As global diabetes cases surge toward 700 million by 2025, according to the International Diabetes Federation , healthcare providers ne
Read More